Citrullinated proteins in Rheumatoid Arthritis;Proteínas citrulinadas en artritis reumatoide

Reumatologia Clinica

Volumn 7, Issue 1, 2011, Pages 68-71

  Olivares Martínez, Elizabeth ^a   Hernández Ramírez, Diego F ^a   Núñez Álvarez, Carlos A ^a   Cabiedes, Javier ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Anti citrullinated protein antibodies; Anticuerpos antiprote nas citrulinadas; Artritis reumatoide; Citrulinaci n; Citrullination; Rheumatoid arthritis

Indexed keywords

AUTOANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ARTICLE; DISEASE SEVERITY; HUMAN; INFLAMMATION; PATHOGENESIS; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

ANIMALS; ANTIBODY SPECIFICITY; ARGININE; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; CITRULLINE; COLLAGEN TYPE II; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FIBRINOGEN; HUMANS; HYDROLASES; PHOSPHOPYRUVATE HYDRATASE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, INBRED LEW; SENSITIVITY AND SPECIFICITY; SUBSTRATE SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; VIMENTIN;

EID: 78651359026     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2009.09.010     Document Type: Article

References (40)

1. Hochberg M.C., Spector T.D. Epidemiology of Rheumatoid Arthritis: Update. Epidem Rev 1990, 12:247-252.
2. Pascual GE. Manifestaciones clínicas articulares. En: Arán, editor. Tratado de Reumatología. España. 1998; p. 437-38.
3. Gregersen P.K., Silver J., Winchester R.J. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis & Rheum 1987, 30:1205-1213.
4. Arrnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for classification of Rheumatoid Arthritis. Arthitis & Rheum 1988, 31:315-324.
5. Nemazee D. Immune complex can trigger specific, T-cell dependent, autoanti-IgG antibody production in mice. J Exp Med 1985, 161:242-256.
6. van Gaalen F.A., Linn-Rasker S.P., van Venrooij W.J., de Jong B.A., Breedveld F.C., Verweij C.L., et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis & Rheum 2004, 50:709-715.
7. van Jaarsveld C.H., ter Borg E.J., Jacobs J.W., Schellekens G.A., Gmelig-Meylinq F.H., van Booma-Frankfort C., et al. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide autoantibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol 1999, 17:689-697.
8. Zeng X., Ai M., Tian X., Gan X., Shi Y., Song Q. Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid Arthritis. J Rheumatol 2003, 30:1451-1455.
9. Sebbag M., Simon M., Vincent C., Masson-Bessière C., Girbal E., Durieux J.J., et al. The antiperinucleal factor and the so called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995, 95:2672-2679.
10. Vossenaar E.R., Després N., Lapointe E., van der Heijden A., Lora M., Senshu T., et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004, 6:142-150.
11. Schellekens G.A., Visser H., de Jong B.A., van den Hoogen F.H., Hazes J.M., Breedveld F.C., et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000, 43:155-163.
12. van Venrooij W.J., Pruijn G.J. Citrullination: A small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2000, 2:249-251.
13. Tarcsa E., Marekov L.N., Mei G., Melino G., Lee S.C., Steinert P.M. Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 1996, 271:30709-30716.
14. Nielen M.M., van Schaardenburg D., Reesink H.W., van de Stadt R.J., van der Horst-Bruinsma I.E., de Koning M.H., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis & Rheum 2004, 50:380-386.
15. Majka D.S., Deane K.D., Parrish L.A., Lazar A.A., Barón A.E., Walker C.W., et al. Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis 2008, 67:801-807.
16. Vossenaar E.R., Zendman A.J., van Venrooij W.J., Prujin G.J. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioassays 2003, 25:1106-1118.
17. Chang X., Yamada R., Suzuki A., Sawada T., Yoshino S., Tokuhiro S., et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology 2005, 44:40-50.
18. Kinloch A., Lundberg K., Wait R., Wegner N., Lim N.H., Zendman A.J., et al. Synovial fluid is a site citrullination of autoantigens in inflammatory arthritis. Arthritis & Rheum 2008, 58:2287-2295.
19. Suzuki A., Yamada R., Chang X., Tokuhiro S., Sawada T., Susuki M., et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003, 34:395-402.
20. Caponi L., Petit-Teixeira E., Sebbag M., Bongiorni F., Moscato S., Pratesi F., et al. A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis 2005, 64:587-593.
21. Barton A., Bowes J., Eyre S., Spreckley K., Hinks A., John S., et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis & Rheum 2004, 50:1117-1121.
22. Martinez A., Valdivia A., Pascual-Salcedo D., Lamas J.R., Fernández-Arquero M., Balsa A., et al. PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatology 2005, 44:1263-1266.
23. Kang C.P., Lee H.S., Ju H., Cho H., Kang C., Bae S.C. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis & Rheum 2006, 54:90-96.
24. Nijenhuis R.L., Mandema E. A new serum factor in patients with rheumatoid arthritis; The antiperinuclear factor. Ann. Rheum. Dis 1964, 23:302-305.
25. Young B.J., Mallya R.K., Leslie R.D., Clark C.J., Hamblin T.J. Anti-keratin antibodies in rheumatoid arthritis. Br. Med J 1979, 2:97-99.
26. Sebbag M., Simon M., Vincent C., Masson-Bessière C., Girbal E., Durieux J.J., et al. The antiperinucleal factor and the so called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995, 95:2672-2679.
27. Girbal-Neuhauser E., Durieux J.J., Arnaud M., Dalbon P., Sebag M., Vincent C., Senshu T., et al. The epitopes targeted by the rheumatoid arthritis-associated antifilagrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999, 162:585-594.
28. Masson-Bessière C., Sebbag M., Girbal-Neuhauser E., Nogueira L., Vincent C., et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001, 166:4177-4184.
29. Cook A.D., Gray R., Ramshaw J., Mackay I., Rowley M. Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis. Arthritis Res Ther 2004, 6:R477-R483.
30. Suzuki A., Yamada R., Ohtake-Yamanaka M., Okazaki Y., Sawada T., Yamamoto K. Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis. Biochem Byophys Res Commun 2005, 333:418-426.
31. Tilleman K., Steendam K., Cantaert T., De Keyser F., Elewaut D., Deforce D. Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides. Rheumatology 2008, 47:597-604.
32. Matsuo K., Xiang Y., Nakamura H., Masuko K., Yudoh K., Noyori K., et al. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther 2006, 8:R175.
33. Kinloch A., Tatzer V., Wait R., Peston D., Lundberg K., Donatien P., et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 2005, 7:R1421-R1429.
34. Olivares-Martínez E. Identificación de los péptidos reconocidos por los anticuerpos anti-péptidos citrulinados presentes en los pacientes con artritis temprana. Tesis de Maestría. Universidad Nacional Autónoma de México. 2008.
35. Lundberg K., Nijenhuis S., Vossenaar E.R., Palmblad K., van Venrooij W.J., Klareskog L., et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 2005, 7:R458-R467.
36. Hill J.A., Southwood S., Sette A., Jevnikar A.M., Bell D.A., Cairns E. Cutting Edge: The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003, 171:538-541.
37. Hill J.A., Bell D.A., Brintnell W., Yue D., Wehlrli B., Jevnikar A.M., et al. Artrhritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 2008, 205:967-979.
38. Klareskog L., Stolt P., Lundberg K., Källberg H., Bengston C., Grunewald J., et al. A new model for etiology of rheumatoid arthritis: smoking may tigger HLA-DR (shared epitope)- restricted immune reactions to antigens modified by citrullination. Arhritis Rheum 2006, 54:38-46.
39. Makrygiannakis D., Hermansson M., Ulfgren A.K., Nicholas A.P., Zendman A.J., Eklund A., et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008, 10:826-850.
40. Klareskog L., Rönnelid J., Lundberg K., Padyukov L., Alfredsson L. Immune to Citrullinated Proteins in rheumatoid arthritis. Ann Rev Immunol 2008, 26:651-675.